Package 55150-353-01

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 55150-353-01
Digits Only 5515035301
Product NDC 55150-353
Product ID 55150-353_2fc24d11-bf17-4007-8a65-d949793a972e
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-353-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2020-02-11
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

IRINOTECAN HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2fc24d11-bf17-4007-8a65-d949793a972e", "openfda": {"upc": ["0355150353019", "0355150354016", "0355150355013"], "unii": ["042LAQ1IIS"], "rxcui": ["1726319", "1726324", "1726333"], "spl_set_id": ["7a30d551-9ea7-47ea-9073-f541bff457a3"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-353-01)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-353-01", "marketing_start_date": "20200211"}], "brand_name": "IRINOTECAN HYDROCHLORIDE", "product_id": "55150-353_2fc24d11-bf17-4007-8a65-d949793a972e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "55150-353", "generic_name": "IRINOTECAN HYDROCHLORIDE", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "IRINOTECAN HYDROCHLORIDE", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA213278", "marketing_category": "ANDA", "marketing_start_date": "20200211", "listing_expiration_date": "20261231"}